Kizildag Yirgin I, Dogan I, Vatansever S, Erturk S
Sisli Etfal Hastan Tıp Bul. 2023; 57(2):195-203.
PMID: 37899816
PMC: 10600626.
DOI: 10.14744/SEMB.2023.63373.
Wang J, Yu X, Shi A, Xie L, Huang L, Su Y
J Cancer Res Clin Oncol. 2023; 149(16):14535-14547.
PMID: 37567986
DOI: 10.1007/s00432-023-05246-4.
Li A, Guo Y, Yin Z, Liu X, Xie G
J Cancer. 2023; 14(2):262-274.
PMID: 36741260
PMC: 9891871.
DOI: 10.7150/jca.77402.
Huang J, Zhuang L, Wang H, Zhong L, Xue S, Tian F
Saudi J Gastroenterol. 2023; 29(1):21-30.
PMID: 36588364
PMC: 10117004.
DOI: 10.4103/sjg.sjg_253_22.
Li J, Zhang C, Guo H, Li S, You Y, Zheng P
Front Immunol. 2022; 13:1019386.
PMID: 36311742
PMC: 9606753.
DOI: 10.3389/fimmu.2022.1019386.
The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
Wang W, Lu Z, Wang M, Liu Z, Wu B, Yang C
Front Immunol. 2022; 13:998236.
PMID: 36110851
PMC: 9468372.
DOI: 10.3389/fimmu.2022.998236.
Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on F-FDG PET/CT for Patients with Colorectal Cancer.
Liu X, Xiang K, Geng G, Wang S, Ni M, Zhang Y
Contrast Media Mol Imaging. 2022; 2022:2586245.
PMID: 35173559
PMC: 8818395.
DOI: 10.1155/2022/2586245.
Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
Hu Y, Gong C, Li Z, Liu J, Chen Y, Huang Y
Mol Cancer. 2022; 21(1):34.
PMID: 35114989
PMC: 8812266.
DOI: 10.1186/s12943-022-01522-y.
Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer.
Li J, Zhang C, Wei J, Zheng P, Zhang H, Xie Y
Front Oncol. 2021; 10:552270.
PMID: 33425719
PMC: 7794018.
DOI: 10.3389/fonc.2020.552270.
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H, Li X, Li Y, Chen B, Zong Z, Shen L
Front Immunol. 2020; 11:603341.
PMID: 33363544
PMC: 7753319.
DOI: 10.3389/fimmu.2020.603341.
Preoperative Splenic Density for the Prediction of Survival and Adjuvant Chemotherapy Benefits in Gastric Cancer.
Zhang W, Zhu C, Wang X, Wang S, Chen X, Chen X
J Cancer. 2020; 11(20):6133-6139.
PMID: 32922553
PMC: 7477414.
DOI: 10.7150/jca.47559.
Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer.
Kanda M, Shimizu D, Sawaki K, Nakamura S, Umeda S, Miwa T
Mol Cancer. 2020; 19(1):131.
PMID: 32847597
PMC: 7448342.
DOI: 10.1186/s12943-020-01251-0.
TNF-like ligand 1A is associated with progression and prognosis of human gastric cancer.
Gao Y, Wang Y, Wang X, Wang Y, Zhang X, Sun X
Onco Targets Ther. 2019; 12:7715-7723.
PMID: 31571922
PMC: 6756834.
DOI: 10.2147/OTT.S210939.
Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer.
Xiong W, Wang W, Huang H, Jiang Y, Guo W, Liu H
J Cancer. 2019; 10(18):4357-4367.
PMID: 31413756
PMC: 6691719.
DOI: 10.7150/jca.31543.
Radiomic signature of F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits.
Jiang Y, Yuan Q, Lv W, Xi S, Huang W, Sun Z
Theranostics. 2019; 8(21):5915-5928.
PMID: 30613271
PMC: 6299427.
DOI: 10.7150/thno.28018.
Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer.
Zhan X, Zhang Y, Zhai E, Zhu Q, He Y
PeerJ. 2018; 6:e4829.
PMID: 29868263
PMC: 5983015.
DOI: 10.7717/peerj.4829.
SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
Kanda M, Tanaka H, Shimizu D, Miwa T, Umeda S, Tanaka C
Oncogene. 2018; 37(39):5355-5366.
PMID: 29858600
DOI: 10.1038/s41388-018-0335-8.
Integrated multigene expression panel to prognosticate patients with gastric cancer.
Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C
Oncotarget. 2018; 9(27):18775-18785.
PMID: 29721160
PMC: 5922354.
DOI: 10.18632/oncotarget.24661.
The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer.
Yu B, Gu D, Zhang X, Liu B, Xie J
J Genet Genomics. 2017; 44(8):375-383.
PMID: 28847472
PMC: 5604254.
DOI: 10.1016/j.jgg.2017.04.008.
Prognostic and Predictive Value of p21-activated Kinase 6 Associated Support Vector Machine Classifier in Gastric Cancer Treated by 5-fluorouracil/Oxaliplatin Chemotherapy.
Jiang Y, Liu W, Li T, Hu Y, Chen S, Xi S
EBioMedicine. 2017; 22:78-88.
PMID: 28687498
PMC: 5552213.
DOI: 10.1016/j.ebiom.2017.06.028.
